vimarsana.com
Home
Live Updates
Should You Pick Johnson & Johnson Stock At $160? : vimarsana.com
Should You Pick Johnson & Johnson Stock At $160?
Johnson & Johnson (NYSE: JNJ) reported its Q4 results last month, with revenues and earnings marginally above the street estimates.
Related Keywords
,
Abiomed ,
Johnson ,
Health Care ,
Trefis High Quality Portfolio ,
Innovative Medicine ,
Johnson Amp Stock ,
Johnson Amp ,
Stelara ,
S Ampp 500 ,
Spravato ,
Jnj Stock ,
Jnj Revenue ,
Jnj Valuation ,
Jnj Q4 ,
vimarsana.com © 2020. All Rights Reserved.